Activation of PERK-ATF4-CHOP pathway as a novel therapeutic approach for efficient elimination of HTLV-1–infected cells

Patients with adult T-cell leukemia (ATL) exhibit a poor prognosis and overall survival rate when treated with standard chemotherapy, highlighting the continued requirement for the development of novel safe and effective therapies for human T-cell leukemia virus type 1 (HTLV-1)-related diseases. In...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Blood Adv
Main Authors: Ikebe, Emi, Matsuoka, Sahoko, Tezuka, Kenta, Kuramitsu, Madoka, Okuma, Kazu, Nakashima, Makoto, Kobayashi, Seiichiro, Makiyama, Junya, Yamagishi, Makoto, Oyadomari, Seiichi, Uchimaru, Kaoru, Hamaguchi, Isao
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2020
Assuntos:
Lymphoid Neoplasia
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7218438/
https://ncbi.nlm.nih.gov/pubmed/32369565
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2019001139
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados